AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 83 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $11,351,000 | +1349.7% | 835,900 | +574.7% | 0.07% | +1550.0% |
Q4 2019 | $783,000 | +61.4% | 123,900 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $485,000 | -66.3% | 123,900 | -52.4% | 0.00% | -66.7% |
Q4 2018 | $1,438,000 | -79.7% | 260,200 | -67.5% | 0.01% | -76.3% |
Q3 2018 | $7,076,000 | +25.5% | 801,366 | +41.8% | 0.04% | +15.2% |
Q2 2018 | $5,639,000 | +4.7% | 565,066 | 0.0% | 0.03% | +6.5% |
Q1 2018 | $5,385,000 | -35.9% | 565,066 | 0.0% | 0.03% | -32.6% |
Q4 2017 | $8,402,000 | -53.2% | 565,066 | -38.1% | 0.05% | -55.3% |
Q3 2017 | $17,948,000 | +5.1% | 912,500 | -23.2% | 0.10% | +3.0% |
Q2 2017 | $17,078,000 | +78.8% | 1,188,500 | +14.4% | 0.10% | +75.4% |
Q1 2017 | $9,554,000 | -11.6% | 1,038,500 | 0.0% | 0.06% | -13.6% |
Q4 2016 | $10,810,000 | -30.0% | 1,038,500 | -39.1% | 0.07% | -29.8% |
Q3 2016 | $15,432,000 | +10.6% | 1,705,300 | -8.5% | 0.09% | +9.3% |
Q2 2016 | $13,947,000 | -17.0% | 1,864,600 | -0.1% | 0.09% | -16.5% |
Q1 2016 | $16,810,000 | +63.9% | 1,865,800 | +135.0% | 0.10% | +63.5% |
Q4 2015 | $10,255,000 | +708.8% | 793,804 | +504.6% | 0.06% | +687.5% |
Q3 2015 | $1,268,000 | – | 131,304 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |